Clinical Trial Detail

NCT ID NCT01817751
Title Sorafenib Tosylate, Valproic Acid, and Sildenafil Citrate in Treating Patients With Recurrent High-Grade Glioma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Virginia Commonwealth University
Indications

malignant glioma

Therapies

Valproic acid

Sorafenib

Age Groups: adult

No variant requirements are available.